These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2700224)

  • 1. Safety aspects of ketoconazole, the most commonly used systemic antifungal.
    Cauwenbergh G
    Mycoses; 1989; 32 Suppl 2():59-63. PubMed ID: 2700224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic hepatitis following ketoconazole treatment.
    Svedhem A
    Scand J Infect Dis; 1984; 16(1):123-5. PubMed ID: 6320358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholestatic hepatitis caused by ketoconazole].
    Bensaude RJ; Furet Y; Autret E; Brottes H; Billard JL; Breteau M
    Ann Gastroenterol Hepatol (Paris); 1988; 24(2):55-7. PubMed ID: 3389721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unintentional rechallenge resulting in a causative relationship between ketoconazole and acute liver injury.
    Chien RN; Sheen IS; Liaw YF
    Int J Clin Pract; 2003 Nov; 57(9):829-30. PubMed ID: 14686574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ketoconazole-induced hepatitis. Case report].
    Henning H; Kasper B; Lüders CJ
    Z Gastroenterol; 1983 Dec; 21(12):709-15. PubMed ID: 6141674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver injury associated with ketoconazole: review of the published evidence.
    Greenblatt HK; Greenblatt DJ
    J Clin Pharmacol; 2014 Dec; 54(12):1321-9. PubMed ID: 25216238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nizoral (Ketoconazole): drug safety communication- potentially fatal liver injury, risk of drug interactions, and adrenal gland problems.
    Clin Infect Dis; 2013 Oct; 57(8):i. PubMed ID: 24195113
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketoconazole and Liver Injury: A Five-Year Update.
    Greenblatt DJ; Mikus G
    Clin Pharmacol Drug Dev; 2019 Jan; 8(1):6-8. PubMed ID: 30599463
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug safety assessment of oral formulations of ketoconazole.
    Gupta AK; Daigle D; Foley KA
    Expert Opin Drug Saf; 2015 Feb; 14(2):325-34. PubMed ID: 25409549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoconazole induced hepatitis.
    Meiring PD; Whitelaw DA
    S Afr Med J; 1987 Oct; 72(8):577-8. PubMed ID: 3672282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute hepatocytic necrosis during ketoconazole therapy for treatment of onychomycosis. National Foundation for Registry and Evaluation of Adverse Effects].
    Van Puijenbroek EP; Metselaar HJ; Berghuis PH; Zondervan PE; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2416-8. PubMed ID: 9864540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoconazole-induced fulminant hepatitis necessitating liver transplantation.
    Knight TE; Shikuma CY; Knight J
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):398-400. PubMed ID: 1832694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis during treatment with ketoconazole].
    Roudot-Thoraval F; Dhumeaux D
    Gastroenterol Clin Biol; 1984 Jan; 8(1):92. PubMed ID: 6321289
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxic hepatitis caused by ketoconazole: a report of 4 cases].
    Vilela MP; Ferraz ML; Franco DR
    Rev Paul Med; 1989; 107(1):57-8. PubMed ID: 2616978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoconazole and hepatitis.
    Klausner MA
    J Am Acad Dermatol; 1992 Jun; 26(6):1028-30. PubMed ID: 1535078
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study.
    Chien RN; Yang LJ; Lin PY; Liaw YF
    Hepatology; 1997 Jan; 25(1):103-7. PubMed ID: 8985273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole-induced hepatotoxicity.
    Bernuau J; Durand F; Pessayre D
    Hepatology; 1997 Sep; 26(3):802. PubMed ID: 9303518
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketoconazole-induced hepatitis: a case with a definite cause-effect relationship.
    van Parys G; Evenepoel C; van Damme B; Desmet VJ
    Liver; 1987 Feb; 7(1):27-30. PubMed ID: 2952860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal hepatitis associated with ketoconazole therapy.
    Duarte PA; Chow CC; Simmons F; Ruskin J
    Arch Intern Med; 1984 May; 144(5):1069-70. PubMed ID: 6324708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rise and Fall of Oral Ketoconazole.
    Gupta AK; Lyons DC
    J Cutan Med Surg; 2015; 19(4):352-7. PubMed ID: 25775613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.